Cardioloxía
Servicio
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (8)
2024
-
Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis
Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 304-313
2023
-
iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy
Circulation Research, Vol. 133, Núm. 2, pp. 108-119
2022
-
Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome
Journal of Clinical Medicine, Vol. 11, Núm. 6
-
Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life
ESC Heart Failure, Vol. 9, Núm. 5, pp. 3071-3078
2021
-
Importance of blood pressure control and adequate neurohormonal treatment in LVAD patients: Comment to paper by Tran T. et al.
Journal of Heart and Lung Transplantation
-
Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice
REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48
2016
-
Impact of previous cardiac surgery on long-term outcome of cavotricuspid isthmus-dependent atrial flutter ablation
Europace, Vol. 18, Núm. 6, pp. 873-880
2015
-
Long-Term Outcome After Ablation of Right Atrial Tachyarrhythmias After the Surgical Repair of Congenital and Acquired Heart Disease
American Journal of Cardiology, Vol. 115, Núm. 12, pp. 1705-1713